Literature DB >> 20688948

Application of a multiplex PCR to cervical cells collected by a paper smear for the simultaneous detection of all mucosal human papillomaviruses (HPVs) and typing of high-risk HPV types 16 and 18.

Shirish Shukla1, Alok C Bharti1, Sutapa Mahata1, Showket Hussain1, Suresh Hedau1, Rajyashri Sharma2, M Radhakrishna Pillai3, Sudhir Krishna4, Shubhada Chiplunkar5, Hemant Tongaonkar6, Bhudev C Das7,1.   

Abstract

A simple paper smear (PS) method for dry collection and storage of cervical specimens was employed to develop an easy multiplex (MPX) PCR for simultaneous detection of generic human papillomaviruses (HPVs) as well as typing of the high-risk HPV-16 and -18, the two clinically most important HPV genotypes, which are responsible for more than 80 % of cervical cancers. Multiplexing was performed with a small amount of DNA eluted by boiling from a single PS punch in a single tube and using a mixture of four pairs of primers specific for the HPV L1 consensus sequence, HPV-16, HPV-18 and the β-globin gene. Sixty HPV-positive biopsies and corresponding PS specimens from cervical cancer patients as well as cervical smears from 100 healthy women with or without abnormal cytology were collected both as PSs and in PBS. Detection of HPV DNA from cervical biopsies collected in PBS and corresponding cervical scrapes on a PS or in PBS by conventional and MPX-PCR showed a concordance of 100 % and adequacy of 93 %. A similar comparative study in cervical scrapes from normal women also revealed 100 % concordance. The technique was validated in a multicentric study at four different national laboratories. PSs collected by different centres showed variable adequacy (73-82 %) but the use of multiple PS discs for DNA extraction significantly increased the adequacy. Integration of PSs with MPX-PCR for the detection and typing of HPVs is a highly convenient, efficient, simple and cost-effective method for large-scale clinico-epidemiological studies and is also suitable for HPV vaccine monitoring programmes in resource-poor settings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688948     DOI: 10.1099/jmm.0.019240-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

1.  Correlation between physical status of human papilloma virus and cervical carcinogenesis.

Authors:  Kezhen Li; Xin Jin; Yong Fang; Changyu Wang; Mei Gong; Pingbo Chen; Jia Liu; Dongrui Deng; Jihui Ai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

2.  HPV-type-specific response of cervical cancer cells to cisplatin after silencing replication licensing factor MCM4.

Authors:  Mitali Das; Shyam Babu Prasad; Suresh Singh Yadav; Arusha Modi; Sunita Singh; Satyajit Pradhan; Gopeshwar Narayan
Journal:  Tumour Biol       Date:  2015-07-19

3.  Detection of human papillomavirus in women attending Pap cervical screening camp at a peripheral hospital of North-Eastern India.

Authors:  Sibnarayan Datta; Manisha Agarwal; Soumya Chatterjee; Hemanta Kumar Gogoi; Vijay Veer; Lokendra Singh
Journal:  Med J Armed Forces India       Date:  2013-08-05

4.  Detection of human papillomavirus infection in oral cancers reported at dental facility: assessing the utility of FFPE tissues.

Authors:  Gaurav Verma; Nikita Aggarwal; Suhail Chhakara; Abhishek Tyagi; Kanchan Vishnoi; Mohit Jadli; Tejveer Singh; Ankit Goel; Durgatosh Pandey; Ankita Sharma; Kiran Agarwal; Urmi Sarkar; Dinesh Chandra Doval; Shashi Sharma; Ravi Mehrotra; Sukh Mahendra Singh; Alok Chandra Bharti
Journal:  Med Oncol       Date:  2021-11-18       Impact factor: 3.064

5.  miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.

Authors:  Yu-Fang Xia; Gui-Hua Pei; Ning Wang; Yan-Ci Che; Feng-Sheng Yu; Fu-Fen Yin; Hai-Xia Liu; Bing Luo; Yan-Kui Wang
Journal:  Virol J       Date:  2017-02-04       Impact factor: 4.099

6.  High frequency of HPV16 European variant E350G among Mexican women from Sinaloa.

Authors:  Elisa Anali Camacho-Ureta; Rocío Susana Mendez-Martínez; Salvador Vázquez-Vega; Ulises Osuna Martínez; Rosalinda Sánchez Arenas; Hipólito Castillo-Ureta; Ignacio Osuna Ramírez; Edith Hilario Torres Montoya; Héctor Samuel López Moreno; Alejandro García-Carranca; José Guadalupe Rendón-Maldonado
Journal:  Indian J Med Res       Date:  2018-09       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.